Since SARS-CoV-2 directly promotes NLRP3 inflammasome activation, and SFN was reported to inhibit the inflammasome activation via Nrf2 activation, SFN may indirectly contribute to diminishing the cytokine storm in patients with COVID-19 [99,100]. This evidence concerns the gene SFN and COVID-19.